Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wittwer

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Chemical Information and Modeling|June 1, 2017
Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1Natalia Khuri, Arik A Zur, Matthias B Wittwer, et al.
The Journal of Biological Chemistry|August 31, 2012
High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approachAvner Schlessinger, Matthias B Wittwer, Amber Dahlin, et al.
Chemical Science|March 16, 2026
Interplay between ligand field strength and the nephelauxetic effect in chromium(iii) complexes with anionic amido ligandsP Yaltseva, B Wittwer, D Leitner, et al.
Chemistry & Biology|April 23, 2013
Chemical development of intracellular protein heterodimerizersDominik Erhart, Mirjam Zimmermann, Olivier Jacques, et al.
Human Molecular Genetics|December 1, 1995
A gene (SRPX) encoding a sushi-repeat-containing protein is deleted in patients with X-linked retinitis pigmentosaA Meindl, M R Carvalho, K Herrmann, et al.
Nature Reviews. Drug Discovery|March 24, 2022
Targeted protein degraders: a call for collective action to advance safety assessmentLyn H Jones, Constance A Mitchell, Lise Loberg, et al.
Journal of Medicinal Chemistry|December 18, 2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modelingMatthias B Wittwer, Arik A Zur, Natalia Khuri, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical ImportanceMaciej J Zamek-Gliszczynski, Vishal Sangha, Hong Shen, et al.
American Journal of Human Genetics|August 27, 1998
Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domainK Gaudenz, E Roessler, N Quaderi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2024
Involvement of CB<sub>1</sub> and CB<sub>2</sub> receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male miceClaudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Chemical Information and Modeling|June 1, 2017
Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1Natalia Khuri, Arik A Zur, Matthias B Wittwer, et al.
The Journal of Biological Chemistry|August 31, 2012
High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approachAvner Schlessinger, Matthias B Wittwer, Amber Dahlin, et al.
Chemical Science|March 16, 2026
Interplay between ligand field strength and the nephelauxetic effect in chromium(iii) complexes with anionic amido ligandsP Yaltseva, B Wittwer, D Leitner, et al.
Chemistry & Biology|April 23, 2013
Chemical development of intracellular protein heterodimerizersDominik Erhart, Mirjam Zimmermann, Olivier Jacques, et al.
Human Molecular Genetics|December 1, 1995
A gene (SRPX) encoding a sushi-repeat-containing protein is deleted in patients with X-linked retinitis pigmentosaA Meindl, M R Carvalho, K Herrmann, et al.
Nature Reviews. Drug Discovery|March 24, 2022
Targeted protein degraders: a call for collective action to advance safety assessmentLyn H Jones, Constance A Mitchell, Lise Loberg, et al.
Journal of Medicinal Chemistry|December 18, 2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modelingMatthias B Wittwer, Arik A Zur, Natalia Khuri, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical ImportanceMaciej J Zamek-Gliszczynski, Vishal Sangha, Hong Shen, et al.
American Journal of Human Genetics|August 27, 1998
Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domainK Gaudenz, E Roessler, N Quaderi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 24, 2024
Involvement of CB<sub>1</sub> and CB<sub>2</sub> receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male miceClaudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, et al.
Pageof 6